Article

Methotrexate-induced erythema multiforme


 

Methotrexate (MTX) is a drug that is commonly used to treat a range of diseases, including inflammatory conditions and malignancies. Although it is effective as a therapy, it is not a benign drug and can have serious adverse effects. In this article, we report and discuss a case of MTX-induced erythema multiforme (EM)...

*Click on the link to the left for a PDF of the full article.

Recommended Reading

A Randomized, Controlled Trial of Panax quinquefolius Extract (CVT-E002) to Reduce Respiratory Infection in Patients With Chronic Lymphocytic Leukemia
MDedge Hematology and Oncology
Double-unit cord blood transplants don't boost survival
MDedge Hematology and Oncology
Did you know: Dr. David Henry reports from ASH
MDedge Hematology and Oncology
Experimental CARS therapy breaks through relapsed CLL
MDedge Hematology and Oncology
Imatinib approved for children with Ph+ acute lymphoblastic leukemia
MDedge Hematology and Oncology
Treatment-related AML rises in non-Hodgkin's lymphoma
MDedge Hematology and Oncology
Genotyping yields clues to treatment-related toxicity and mortality
MDedge Hematology and Oncology
Bone marrow fibrosis reversal after use of hydroxyurea in a patient with myelofibrosis
MDedge Hematology and Oncology
POEMS syndrome: a significant clinical response to lenalidomide
MDedge Hematology and Oncology
Company suspends enrollment in drug trials
MDedge Hematology and Oncology